Mark Samuels, chief executive of the British Generic Manufacturers Association (BGMA), has warned that the agreement could reduce the number of medicine suppliers serving the NHS, raising the risk ...

As the US and Europe experiences shortages of crucial medicines, Ben Hargreaves looks at how a once thriving generics industry is now struggling, with many companies seeking to exit the space.

Whether you're a Java programmer curious about how to integrate LLM-based applications into your local data stores, or a Spring Boot developer who wants to integrate services with real-time language ...

18 months after it opened an investigation into Teva to see if it illegally blocked generic versions of its big-selling multiple sclerosis drug Copaxone, the European Commission has said it thinks ...

Europe’s regulator has called for generic medicines from manufacturers including Novartis’ Sandoz unit, Teva and Mylan to be pulled from the market, after US inspectors found evidence that ...

MCCPDC bypasses the "middlemen" by working directly with distributors and manufacturers to offer generic drugs at decreased costs. "Our most valuable partners are the manufacturers and ...

Groups advocating for New York retirees are backing a State Legislature bill requiring drug manufacturers to notify officials of any “pay-for-delay” actions preventing a brand-name medication from ...

Electric cars, climate credit schemes, diverse boardrooms and legal weed: How California exports its ideas and policies across the U.S. A federal judge blocked President Trump’s order banning ...